SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001125282-03-004459
Filing Date
2003-07-29
Accepted
2003-07-29 17:18:58
Documents
6
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 AMEND NO. 3 TO ANNUAL REPORT b325939_10ka.htm 10-K/A 1388517
3 GRAPHIC emptybox.gif GRAPHIC 1218
4 GRAPHIC tickedbox.gif GRAPHIC 1267
5 EXHIBIT 23.1 b325939ex23_1.htm EX-23.1 2003
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER b325939_ex99-1.txt EX-99.1 1480
7 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER b325939_ex99-2.txt EX-99.2 1407
  Complete submission text file 0001125282-03-004459.txt   1397950
Mailing Address
Business Address 420 CHIPETA WAY STE 240 SALT LAKE CITY UT 84108-1256 8015834939
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23272 | Film No.: 03809406
SIC: 2836 Biological Products, (No Diagnostic Substances)